Axon Reports Record Revenues over $90 Million in Third Quarter 2017

SCOTTSDALE, Ariz., Nov. 7, 2017 /PRNewswire/ -- Axon Enterprise, Inc. (Nasdaq: AAXN), today reported financial results for the third quarter ended September 30, 2017.

TASER's Axon brand includes a growing suite of connected products and services from body cameras and digital evidence management tools to mobiles apps.

In Q3, we delivered solid growth against our long-term plan of delivering our end-to-end technology platform for public safety. We demonstrated leadership across product categories, furthering our dominance in TASER weapons and strengthening our position in body-worn cameras. Since our last update, we also made strides with our new in-car Axon Fleet offering, completed beta testing on Signal Sidearm, and rolled out new software updates and an entirely new software capability, Axon Citizen.

At the same time, we also made necessary investments to strengthen our finance and information technology functions to better position our company for long-term sustainable growth and profitability. While we continue to expand our addressable market with leading technology solutions and scale our organization accordingly, we are transitioning our body camera business to focus on improved operating leverage in 2018.

The body camera business is evolving from the early market formation and growth phase towards the profitability phase. As the body camera business enters the next phase, we are accelerating innovation. We have several major new growth initiatives, including the Axon Fleet in-car video system, International Markets, and Records Management System ("RMS") where we are expanding our market-leading software and sensors platform with significant new revenue opportunities. We intend to provide more information on the profitability of our maturing business lines and significant new market opportunities at our upcoming Investor & Analyst Day on November 16 in New York.

We look forward to discussing our Q3 results on our conference call at 5 p.m. ET.

Summary of Q3 2017 Results:

Net sales increased 26% to $90.3 million in Q3 2017 compared to $71.9 million in Q3 2016. International sales were $17.1 million in the current quarter, up from $13.4 million in Q2 2017 and $11.3 million in Q3 2016.

Consolidated gross margin was 55% in Q3 2017 compared to 65% in Q3 2016. We discuss gross margin by segment in the sections below.

Gross profit of $49.8 million was impacted by the following factors:

  • $1.4 million of duplicate data storage and migration costs as we completed the transition from Amazon Web Services ("AWS") to Microsoft Azure.
  • $1.3 million of additional costs associated with deploying hardware into beachhead international markets at aggressive leaders' pricing. We have substantially completed shipments against these contracts and do not expect further shipments to materially affect Q4 or 2018.
  • $1.1 million of associated costs with the launch of Axon Fleet, including early customer accommodations and discounts, higher implementation costs as we refine our roll-out process, and deferred hardware revenue effects due to bundling.

Total operating expenses in Q3 2017 were $50.6 million compared to $35.5 million in Q3 2016.

Operating expenses were $3.1 million above guidance largely based on the following factors:

  • $1.4 million from increased commissions ($0.6 million) and selling expenses ($0.8 million) associated with sales that were $7.9 million above our internal budget for sales of $82.4 million.
  • $1.5 million in expenses related to international tax restructuring, remediation of material weaknesses and build out of infrastructure for new reporting guidelines (ASC 606) that take effect in Q1 2018. The tax restructuring is now complete and should yield a significant return on investment by reducing our effective tax rate by more than 10 percentage points, streamlining our administrative overhead, and simplifying our inventory management. The investments we are making in our core support functions and processes are bringing a new level of rigor and allowing us to upgrade our IT systems for scale.

Selling, general and administrative expenses were $36.4 million. SG&A also reflected new recurring amortization expense related to the acquisition of our Australian distributor, which was not in our original forecast. This acquisition sets the foundation for us to drive greater sales at higher net margins via direct customer relationships going forward.

Research and development expenses were $14.2 million in the quarter, which reflects our investment in new product offerings, including Axon Fleet, RMS, and another significant program that we expect to announce and ship in 2018.

Loss from operations was $0.8 million in Q3 2017 compared to income of $11.1 million in Q3 2016. The decrease in operating income was tied to gross margin compression as well as an increase in total operating expenses in the quarter.

Net income for Q3 2017 was $0.4 million, or $0.01 per diluted share, compared to $3.8 million, or $0.07 per diluted share, in Q3 2016.

Adjusted EBITDA for Q3 2017 was $7.0 million compared to $13.8 million in Q3 2016. We calculate adjusted EBITDA by adding back $4.0 million in stock-based compensation expense to EBITDA.

In Q3 2017, cash provided by operating activities was $6.6 million. Cash, cash equivalents and investments were $61.8 million at September 30, 2017, or flat sequentially, even after funding the $4.2 million purchase price of Breon Enterprises, our Australian distributor.

We are executing on our stated objective of managing down inventory. Total inventory in the quarter decreased to $52.7 million, from $60.7 million at the end of Q2 2017. We remain on track to be below $50 million of inventory by year end.

TASER Weapons:

TASER Weapons segment revenue increased 12% to $59.4 million in Q3 2017 compared to $52.9 million in Q3 2016 as we executed against our mission of making a TASER conducted electric weapon ("CEW") available to every officer.

TASER Weapons segment gross margin was 68% in Q3 2017 compared to 72% in Q3 2016. The weapons margin performance in Q3 reflects a greater mix of X2 weapons and the pricing impact of bundling with initial Axon Fleet orders. Our entry into the Axon Fleet market is showing signs of early success, but with new product launches into new markets, our ramp carries increased costs of deployment as well as customer accommodations and discounts. Under generally accepted accounting principles, a discount on one element of a multi-element deal must be applied proportionally across the elements, regardless of the appearance on the customer invoice statement.

Three large domestic weapons orders benefited the quarter including a large state's department of public safety, a metropolitan police department, and a US federal agency. Internationally, we are demonstrating traction on our improved go-to-market strategy in which we are investing in direct sales teams rather than relying on third-party distributors. For the first time, this quarter we offered our TASER 60 plan in the UK and received an order for 2,700 X2 weapons via the TASER 60 Premium subscription plan. We also received another international order for more than 1,000 X26P weapons. Both orders resulted from our improved international sales strategy.

The TASER 60 payment plan, which we introduced in Q2 2016, continues to be well-received. In Q3, approximately 43% of units ordered, including from international customers, were on the TASER 60, Officer Safety Plan, or TASER Assurance Plan payment options. The TASER 60 is a five-year annual payment plan that allows agencies to reliably budget for the TASER CEW in their operating budget, which is simpler for many customers than procuring and maintaining the CEW via their capital budgets. The payment plan is also a key step in our long-term strategy of shortening upgrade cycles, increasing the ratio of TASER CEWs to patrol officers, and setting the stage to launch additional software and service plans in 2018.

Software & Sensors:

Software and Sensors segment revenue grew 63% year over year to $30.8 million in Q3 2017 compared to $18.9 million in Q3 2016.

Annual recurring service revenue doubled year over year to $63.7 million in Q3 2017 compared to $32.0 million in Q3 2016.

Both product and service revenue broke records in Q3 2017. Software and Sensors product revenue was $14.6 million in Q3 2017 compared to $10.3 million in Q3 2016. Software and Sensors service revenue was $16.3 million in Q3 2017 compared to $8.7 million in Q3 2016.

Software and Sensors segment gross margin was 31% in Q3 2017 compared to 45% in Q3 2016.

Service gross margin was 64% in Q3 2017, compared to 81% in Q3 2016. Cost of services delivered was $5.9 million in the third quarter. The data migration from AWS to Microsoft Azure's government cloud negatively affected Software and Sensors service gross margin. We incurred a total of $1.4 million of migration and duplicate storage cost in Q3 compared with our previous forecast of $0.8 million. Additionally, cost of services included $0.5 million of intangible asset amortization expense related to the Misfit acquisition, which was put into service in 2017 after previously having been classified as research and development expense. Net of the duplicate storage and migration costs and the amortization reclassification, cost of services delivered would have been $4.0 million, and service margin would have been 75%.

While the migration of existing data was completed, we expect to incur another $1.0 million in expense to fully compete the transition to Microsoft Azure.

Hardware product margin (excluding services) was negative 5% in Q3 2017 compared to positive 15% in Q3 2016. Gross margin was largely affected by three factors: the large hardware shipments at low pricing into international beachhead markets, greater discounts and costs during the Axon Fleet launch, and costs and discounts associated with discounts on up-front hardware on multi-year contracts.

Hardware gross margin for the segment in the quarter reflects pricing on certain large international beachhead accounts at levels that we do not expect going forward.

Our early Axon Fleet deals, some of which were booked in 2015 and early 2016, included discounted pricing and strategic concessions on accessories such as routers needed for data flows. We started to meaningfully scale Axon Fleet with approximately 1,600 units shipped in Q3 2017. Newer Axon Fleet deals do not have the same level of discounting as earlier contracts.

Further, we did not receive the full benefit we expected from standardizing the terms and conditions across our contracts as it relates to cancellation provisions. These provisions will allow us to recognize the revenue allocated to the hardware at the time of shipment. We expect to see some uplift in margins in Q4 2017 to the extent we ship a larger percentage of contracts with the modified contract terms.

We expect significant improvements in hardware margins in our body camera segment over the next several quarters, and expect margins to exceed 25% in Q1 2018, excluding Axon Fleet pass-through hardware.

While the segment's margin performance in the period obscures the long-term margin strength in our business model, our positioning has never been stronger in the market. Customer demand remains very high as highlighted by our $78.0 million in bookings in the period. Recent investments in new product functionality and better performance are driving larger contracts upfront and early contract renewals with higher annual contract values. Our customers see and appreciate the value in our end-to-end solution. This total solution improves the workflow of everyone in the network, including officers, prosecutors and defenders.

For example, one of our earliest metropolitan area body-worn camera customers recently chose to upgrade its camera contract before it came up for renewal. The department signed onto our Officer Safety Plan, which bundles one TASER smart weapon, two body-worn camera upgrades, unlimited Evidence.com storage, and full warranty, repair and replacement coverage over a five-year contract, and carries an MSRP of $99 per month per officer.

As of the end of the third quarter of 2017, 38 of the 68 U.S. major city law enforcement agencies have purchased Axon body-worn cameras and/or its digital evidence management solution: Albuquerque, Atlanta, Austin, Baltimore, Baltimore County, Charlotte-Mecklenburg, Chicago, Cincinnati, Cleveland, Dallas, Denver, Fort Worth, Fresno, Las Vegas, Los Angeles, Louisville, Memphis, Mesa, Miami, Milwaukee, Minneapolis, Montgomery County, New Orleans, Omaha, Philadelphia, Pittsburgh, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, San Jose, Seattle, Tampa, Toronto, Tucson, Washington DC, and Wichita.

Axon's Evidence.com platform user count continued to grow, extending our market leadership. During the three months ended September 30, 2017, we booked approximately 18,400 seats on our digital evidence management platform, Evidence.com, net of renewals. Since inception, we have booked cumulative Evidence.com licenses of approximately 187,400.

We also recorded 12 competitor conversion wins in Q3 2017 where our body-worn camera or Axon Fleet offering displaced a competitor, and we recorded four expansions where a state or major city police agency chose to upsize their contracts and expand their reliance upon the Axon network.

Product Pipeline:

We are pleased with the pace of our software product development as we study our customers' market needs and respond with technology solutions. Since our last quarterly update in August, we released Axon Citizen, a public safety portal that allows community members to submit evidence directly to law enforcement agencies for crimes under investigation. The two components to Axon Citizen are a tool that allows one-on-one communication between an officer and the citizen and a capability that allows a community-wide broadcast requesting information on a specific crime. The one-on-one tool is available now for Axon customers signed up for early access and will be available to U.S. customers on the Evidence.com Pro, Ultimate, or Unlimited licensing tiers at no incremental cost later this year. The large-event community broadcast Citizen tool will be priced later this year as an Enterprise add-on.

Evidence.com is continuously improving as we roll out monthly updates to agency customers. In Q3 2017, we released enhancements to our search, access control, and reporting functionalities. These updates were driven by customer feedback and collaboration with our sales, customer support, and product management teams. Positive customer feedback validates our cloud-based digital evidence management approach.

We are seeing strong customer interest in Signal Sidearm, which we announced in Q1 2017. We finished beta testing in October and it is available to ship for all Axon customers in Q4 2017. Signal Sidearm is a smart sensor that attaches to most firearm holsters currently used by law enforcement. When a firearm is removed from its holster, a wireless alert is sent to all Axon cameras within range to begin recording and capture buffered video from a set number of seconds before the incident.

As we have said before, we are investing in artificial intelligence ("AI") and machine learning. While our AI Research investments are pre-revenue, we received a major validation of our growing capability in the quarter. The Los Angeles Police Department chose Axon over several competitors to be its AI technology supplier for a special video analytics project. A panel of reviewers evaluated each competitor's work and Axon's solution resulted in the most accurate results with the greatest potential to assist the department directly. LAPD received a federal grant to pay for the project, and though it is not material to results, we believe the win points to our strategic advantage of having an industry leading team specifically focusing on AI solutions for law enforcement.

Our Records Management System ("RMS") remains on track to ship in 2018 to select agencies in our early access program. In Q3 2017, we signed one major agency and a number of smaller agencies as early access RMS partners. Customers tell us that our RMS offering cannot come soon enough — today's police officers can spend up to two-thirds of a given shift performing administrative tasks. Outdated software prevents front-line officers from maximizing their time spent in their communities. In 2016, we announced our plans to reduce police paperwork by 80% within the next ten years through an RMS solution that seamlessly integrates with an agency's computer-aided dispatch system (CAD). Axon's cloud-based digital evidence management solution, Evidence.com and our wide array of audio video sensors using new AI processing capabilities will automate the capture and processing of information. We are executing against that goal.

Outlook:

We expect full year revenue growth to exceed 25%, well above our original expectation of 15% to 20% growth in 2017.

We expect Q4 2017 gross margin to show slight improvement, benefiting from lower data migration expenses and higher pricing on upfront hardware on multi-year deals, but offset by our aggressive move into the in-car video market.

We expect a sequential increase in operating expenses of 5% to 8% in Q4 2017, driven by R&D investments and seasonal sales and marketing activities. We are actively working to adjust the trajectory of our operating expense growth rate to drive leverage.

We remain excited about the strength of our team and our product offering and look forward to providing an overview of our long-term vision at our Investor & Analyst Day in New York on November 16, which will be Webcast at http://investor.axon.com/.

Signed,

Rick Smith, CEO
Luke Larson, President
Jawad Ahsan, CFO

QUARTERLY CONFERENCE CALL & WEBCAST:

The Company will host its Q3 2017 earnings conference call on Tuesday, November 7, 2017 at 5 p.m. ET. To join the live audio presentation, please dial toll free 877-303-9126, or for international callers, please dial +1-253-237-1156.

The call will be available via live audio webcast and archived replay on Axon's investor relations website at http://investor.axon.com/.

The Company has posted supplemental materials including its key operating metrics on its website to provide additional information about our third quarter financial results.

Statistical Definitions:

Bookings are an indication of the activity the Company is seeing relative to Axon hardware and Evidence.com. We consider bookings to be a statistical measure defined as the sales contract value (not invoiced sales), including contractual optional periods we expect to be exercised, net of cancellations, placed in the relevant fiscal period, regardless of when the products or services ultimately will be provided. Most bookings will be invoiced in subsequent years.

Due to municipal government funding rules, in some cases certain of the future year amounts included in bookings are subject contractual options being exercised and to budget appropriation or other contract cancellation clauses. Although Axon has entered into contracts for the delivery of products and services in the future and anticipates the contracts will be completed, if agencies do not exercise contractual options, do not appropriate money in future year budgets or do enact a cancellation clause, revenue associated with these bookings will not ultimately be recognized, resulting in a future reduction to bookings. In the third quarter of 2017, the Company did not record any reversals related to prior period bookings due to non-appropriation or other cancellation reasons.

For more information relative to our revenue recognition policies, please reference our SEC filings.

Non-GAAP Measures:

To supplement the Company's financial results presented in accordance with GAAP, we present the non-GAAP financial measures of EBITDA, Adjusted EBITDA and Free Cash Flow. Our management uses these non-GAAP financial measures in evaluating the Company's performance in comparison to prior periods. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance, and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented at the end of the release.

EBITDA is defined as consolidated net income before interest expense, income taxes and depreciation and amortization. Adjusted EBITDA, as presented herein, is defined as EBITDA before certain other items, including: stock-based compensation; net gain/loss on write-down/disposal of property, equipment and intangible assets; and loss on impairment.

Free Cash Flow is defined as cash flows provided by operating activities minus purchases of property, plant and equipment, and intangible assets.

Caution on Use of Non-GAAP Measures

Although these non-GAAP financial measures are not consistent with GAAP, management believes investors will benefit by referring to these non-GAAP financial measures when assessing the Company's operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:

these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company's GAAP financial measures; these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company's GAAP financial measures; these non-GAAP financial measures should not be considered to be superior to the Company's GAAP financial measures; and these non-GAAP financial measures were not prepared in accordance with GAAP and investors should not assume that the non-GAAP financial measures presented in this earnings release were prepared under a comprehensive set of rules or principles. Further, these non-GAAP financial measures may be unique to the Company, as they may be different from similarly titled non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies.

About Axon

The Axon network is a network of devices, apps and people that helps law enforcement become smarter and safer. Our mission is to protect life. Our technologies give law enforcement the confidence, focus and time they need to keep their communities safe. Our products impact every aspect of an officer's day-to-day experience:

  • In the field - Our Smart Weapons offer a less-lethal intermediate use of force response and our body-worn and in-car cameras collect video evidence to capture the truth of an incident; and our mobile applications enable simple evidence collection.
  • At the station - Our secure, cloud-based digital evidence management solution allows officers and command staff to manage, review, share and process digital evidence using forensic, redaction, transcription, and other tools.
  • In the courtroom - Our solutions for prosecutors make collaborating across jurisdictions and agencies easy so that cases can be resolved quickly.

We work hard for those who put themselves in harm's way for all of us. To date, there are more than 187,400 licensed users from around the world and more than 191,000 lives and countless dollars have been saved with the Axon network of devices, apps and people. Learn more at www.axon.com or by calling (800) 978-2737.

Axon, the "Axon Delta" logo, Axon network, Axon Body 2, Axon Fleet, Axon Flex 2, Axon Citizen, Axon Signal, Evidence.com, Smart Weapons, and TASER are trademarks of Axon Enterprise, Inc., some of which are registered in the U.S. and other countries. For more information, visit www.axon.com/legal. All rights reserved.

Follow Axon here:

Axon on Twitter: https://twitter.com/axon_us, Axon on Facebook: https://www.facebook.com/Axon.ProtectLife/

Note to Investors

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding our expectations, beliefs, intentions or strategies regarding the future. We intend that such forward-looking statements be subject to the safe-harbor provided by the Private Securities Litigation Reform Act of 1995. The forward-looking information is based upon current information and expectations regarding Axon Enterprise, Inc. These estimates and statements speak only as of the date on which they are made, are not guarantees of future performance, and involve certain risks, uncertainties and assumptions that are difficult to predict. Axon Enterprise, Inc. assumes no obligation to update the information contained in this press release, except as required by law.

We caution that these statements are qualified by important factors that could cause actual results to differ materially from those reflected by the forward looking statements herein. Such factors include, but are not limited to: market acceptance of our products; our dependence on sales of our TASER X26P and X2 CEWs; acceptance of our Evidence.com software as a service delivery model by our law enforcement customers; our ability to design, introduce and sell new products; delays in development schedules; rapid technological change and competition; product defects; breach of our security measures resulting in unauthorized access to customer data; outages and disruptions relating to our Evidence.com service; budgetary and political constraints of prospects and customers; the length of our sales cycle and our ability to realize benefits from our marketing and selling efforts; our exposure to cancellations of government contracts due to appropriation clauses; changes in civil forfeiture laws; the long-term revenue recognition cycle for our SaaS Evidence.com product; our reliance on third party cloud-based storage providers; litigation risks resulting from alleged product-related injuries and media publicity concerning allegations of deaths occurring after use of the TASER device and the negative impact this publicity could have on sales; the outcome of pending or future litigation; our ability to protect our intellectual property as well as intellectual property infringement claims and relating litigation costs; challenges obtaining and enforcing our patent rights in foreign countries; risks of governmental regulations, including regulations of our products by the United States Consumer Product Safety Commission, regulation of our products as a "crime control" product by the Federal government, state and local government regulation and foreign regulation and the adverse effects that could result from our products being classified as firearms by the United States Bureau of Alcohol, Tobacco, Firearms and Explosives; regulatory and political challenges presented by international markets; the possibility that the United States may withdraw from or materially modify the North American Free Trade Agreement; the adverse effect of the United Kingdom's exit from the European Union; our compliance with regulations governing the environment, including but not limited to, regulations within the European Union; regulations relating to voice, data and communications services; regulations relating to conflict minerals; our dependence on third party suppliers for key components of our products; component shortages; rising costs of raw materials and transportation relating to petroleum prices; that we may experience declines in gross margins due to a shift in product sales from CEWs to Axon devices; our ability to manage our growth and increase manufacturing production to meet demand; establishment and expansion of our direct and indirect distribution channels; our ability to pursue sales directly with customers; risks relating to acquisitions and joint ventures; goodwill impairment; catastrophic events; the adverse effects on our operations and financial results from foreign currency fluctuations; fluctuations in our effective tax rate; counter-party risks relating to cash balances held in excess of FDIC insurance limits; employee retention risks; volatility in our stock price; quarterly fluctuations in our operating results; and other factors identified in documents filed by us with the Securities and Exchange Commission, including those set forth in our Form 10-K for the year ended December 31, 2016.

Please visit http://investor.axon.com, https://www.axon.com/press, www.twitter.com/axon_us and https://www.facebook.com/Axon.ProtectLife/ where Axon discloses information about the company, its financial information and its business.

Visit our Investor Relations Safe Harbor Statement at: http://investor.axon.com/safeHarbor.cfm

For investor relations information please contact Andrea James via email at IR@axon.com.

 

AXON ENTERPRISE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except per share data)



Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


2017


2016

Net sales from products

$

73,985



$

63,204



$

208,351



$

167,745


Net sales from services

16,277



8,678



40,796



18,423


Net sales

90,262



71,882



249,147



186,168


Cost of product sales

34,573



23,664



91,817



61,172


Cost of service sales

5,924



1,653



13,258



4,230


Cost of sales

40,497



25,317



105,075



65,402


Gross margin

49,765



46,565



144,072



120,766


Operating expenses:








Sales, general and administrative

36,398



28,121



99,079



77,333


Research and development

14,166



7,358



39,618



20,995


Total operating expenses

50,564



35,479



138,697



98,328


Income (loss) from operations

(799)



11,086



5,375



22,438


Interest and other income (expense), net

1,430



(455)



3,320



(460)


Income before provision for income taxes

631



10,631



8,695



21,978


Provision for income taxes

209



6,788



1,417



11,022


Net income

$

422



$

3,843



$

7,278



$

10,956


Net income per common and common equivalent shares:








Basic

$

0.01



$

0.07



$

0.14



$

0.21


Diluted

$

0.01



$

0.07



$

0.14



$

0.20


Weighted average number of common and common equivalent shares outstanding:








Basic

52,831



52,206



52,663



52,791


Diluted

53,843



53,141



53,762



53,656


 

AXON ENTERPRISE, INC.

SEGMENT REPORTING

(Unaudited)

(dollars in thousands)



Three Months Ended September 30, 2017


Three Months Ended September 30, 2016


TASER
Weapons


Software and
Sensors


Total


TASER
Weapons


Software and
Sensors


Total













Net sales from products

$

59,416



$

14,569



$

73,985



$

52,938



$

10,266



$

63,204


Net sales from services



16,277



16,277





8,678



8,678


Net sales

59,416



30,846



90,262



52,938



18,944



71,882


Cost of product sales

19,237



15,336



34,573



14,973



8,691



23,664


Cost of service sales



5,924



5,924





1,653



1,653


Cost of sales

19,237



21,260



40,497



14,973



10,344



25,317


Gross margin

40,179



9,586



49,765



37,965



8,600



46,565


Sales, general and administrative

20,575



15,823



36,398



16,439



11,682



28,121


Research and development

1,856



12,310



14,166



1,408



5,950



7,358


Income (loss) from operations

$

17,748



$

(18,547)



$

(799)



$

20,118



$

(9,032)



$

11,086














Gross margin %

67.6

%


31.1

%


55.1

%


71.7

%


45.4

%


64.8

%

Operating margin %

29.9

%


(60.1)

%


(0.9)

%


38.0

%


(47.7)

%


15.4

%




Nine Months Ended September 30, 2017


Nine Months Ended September 30, 2016


TASER
Weapons


Software and
Sensors


Total


TASER
Weapons


Software and
Sensors


Total













Net sales from products

$

170,103



$

38,248



$

208,351



$

144,307



$

23,438



$

167,745


Net sales from services



40,796



40,796





18,423



18,423


Net sales

170,103



79,044



249,147



144,307



41,861



186,168


Cost of product sales

53,341



38,476



91,817



43,998



17,174



61,172


Cost of service sales



13,258



13,258





4,230



4,230


Cost of sales

53,341



51,734



105,075



43,998



21,404



65,402


Gross margin

116,762



27,310



144,072



100,309



20,457



120,766


Sales, general and administrative

55,283



43,796



99,079



46,395



30,938



77,333


Research and development

5,931



33,687



39,618



3,773



17,222



20,995


Income (loss) from operations

$

55,548



$

(50,173)



$

5,375



$

50,141



$

(27,703)



$

22,438














Gross margin %

68.6

%


34.6

%


57.8

%


69.5

%


48.9

%


64.9

%

Operating margin %

32.7

%


(63.5)

%


2.2

%


34.7

%


(66.2)

%


12.1

%

 

AXON ENTERPRISE, INC.

Software and Sensors Bookings by Quarter

(Unaudited)

(in thousands)



September 30, 2017


June 30, 2017


March 31, 2017


December 31, 2016


September 30, 2016











Bookings

$

77,976



$

81,942



$

60,080



$

72,509



$

57,491






















 

Software and Sensors Future Contracted Revenue

(Unaudited)

(in thousands)



September 30,
2017


June 30, 2017

Cumulative bookings, net of cancellations

$

684,577



$

606,601


Cumulative recognized revenue

(190,424)



(160,500)


Future contracted revenue

$

494,153



$

446,101


Future contracted revenue for the Software and Sensors segment represents a statistical measure defined as cumulative bookings minus cumulative recognized revenue related solely to that segment. Future contracted revenues are an indication of momentum of longer-term contracts being signed and the expectations of future revenues in the Software and Sensors segment. These financial metrics are exclusive of TASER Cam recorder revenues.

AXON ENTERPRISE, INC.

UNIT SALES STATISTICS

(Unaudited)

Units in whole numbers



Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


Unit
Change


Percent
Change


2017


2016


Unit
Change


Percent
Change

















TASER X26P

13,472



23,259



(9,787)



(42.1)

%


47,031



58,385



(11,354)



(19.4)

%

TASER X2

21,896



12,481



9,415



75.4



54,423



34,697



19,726



56.9


TASER Pulse and Bolt

2,944



1,936



1,008



52.1



8,863



6,522



2,341



35.9


Cartridges

643,077



544,671



98,406



18.1



1,818,345



1,424,656



393,689



27.6


Axon Flex

8,298



4,961



3,337



67.3



20,772



11,026



9,746



88.4


Axon Body

28,669



25,093



3,576



14.3



75,864



40,977



34,887



85.1


Axon Fleet

1,598





1,598



*



1,598





1,598



*


Axon Dock

6,440



6,432



8



0.1



19,584



11,236



8,348



74.3


TASER Cam

1,512



1,323



189



14.3



4,187



6,460



(2,273)



(35.2)



* Not meaningful

 

AXON ENTERPRISE, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

Dollars in thousands



Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


2017


2016









Net income

$

422



$

3,843



$

7,278



$

10,956


   Depreciation and amortization

2,277



901



5,677



2,744


   Interest expense, net

49





132



10


   Provision for income taxes

209



6,788



1,417



11,022


EBITDA

$

2,957



$

11,532



$

14,504



$

24,732










Adjustments:








Stock-based compensation expense

$

4,000



$

2,216



$

11,423



$

6,742


Net loss on disposal of property, equipment and intangible assets



64





61


Adjusted EBITDA

$

6,957



$

13,812



$

25,927



$

31,535


Adjusted EBITDA as a percentage of net sales

7.7

%


19.2

%


10.4

%


16.9

%

Net income as a percentage of net sales

0.5

%


5.3

%


2.9

%


5.9

%









Composition of stock-based compensation:



Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


2017


2016









Cost of product and service sales

$

134



$

77



$

368



$

247


Sales, general and administrative

2,099



1,348



6,282



4,197


Research and development

1,767



791



4,773



2,298



$

4,000



$

2,216



$

11,423



$

6,742


 

AXON ENTERPRISE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)



September 30, 2017


December 31, 2016


(Unaudited)



ASSETS




Current Assets:




Cash and cash equivalents

$

43,471



$

40,651


Short-term investments

18,372



48,415


Accounts and notes receivable, net

51,204



39,466


Inventory, net

52,692



34,841


Prepaid expenses and other current assets

23,002



13,858


Total current assets

188,741



177,231






Property and equipment, net

31,263



24,004


Deferred income tax assets, net

22,845



19,515


Intangible assets, net

20,758



15,218


Goodwill

14,923



10,442


Long-term investments



234


Long-term accounts and notes receivable, net of current portion

32,543



17,602


Other assets

16,534



13,917


Total assets

$

327,607



$

278,163






LIABILITIES AND STOCKHOLDERS' EQUITY




Current Liabilities:




Accounts payable

$

12,354



$

10,736


Accrued liabilities

22,431



18,248


Current portion of deferred revenue

60,453



45,137


Customer deposits

2,648



2,148


Current portion of business acquisition contingent consideration

1,735



1,690


Other current liabilities

470



80


Total current liabilities

100,091



78,039






Deferred revenue, net of current portion

51,574



40,054


Liability for unrecognized tax benefits

1,763



1,896


Long-term deferred compensation

3,533



3,362


Business acquisition contingent consideration, net of current portion

2,715



1,635


Other long-term liabilities

1,851



2,289


Total liabilities

161,527



127,275






Stockholders' Equity:




Preferred stock




Common stock

1



1


Additional paid-in capital

197,978



187,656


Treasury stock

(155,947)



(155,947)


Retained earnings

125,256



118,275


Accumulated other comprehensive income

(1,208)



903


Total stockholders' equity

166,080



150,888


Total liabilities and stockholders' equity

$

327,607



$

278,163


 

AXON ENTERPRISE, INC.

SELECTED CASH FLOW INFORMATION

(Unaudited)

(in thousands)



Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


2017


2016









Net income

$

422



$

3,843



$

7,278



$

10,956


Depreciation and amortization

2,277



901



5,677



2,744


Stock-based compensation

4,000



2,216



11,423



6,742


Net cash provided by (used in) operating activities

6,611



11,623



(5,835)



21,959


Net cash provided by investing activities

7,514



639



9,551



2,285


Net cash provided by (used in) financing activities

(253)



719



(1,600)



(33,801)


Cash and cash equivalents, end of period

43,471



50,600



43,471



50,600



















Three Months Ended September 30,


Nine Months Ended September 30,


2017


2016


2017


2016









Net cash provided by (used in) operating activities

$

6,611



$

11,623



$

(5,835)



$

21,959


Purchases of property and equipment

(3,331)



(1,371)



(9,072)



(3,335)


Purchases of intangible assets

(261)



(154)



(431)



(339)


Purchase of property and equipment and intangible assets, including goodwill, in connection with business acquisitions

(4,150)





(10,629)




Free cash flow (deficit), a non-GAAP measure

$

(1,131)



$

10,098



$

(25,967)



$

18,285


CONTACT:
Investor Relations
Axon Enterprise, Inc.
IR@axon.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/axon-reports-record-revenues-over-90-million-in-third-quarter-2017-300551219.html

SOURCE Axon

News Provided by Acquire Media